XML 23 R7.htm IDEA: XBRL DOCUMENT v3.24.0.1
Consolidated Statements of Equity - USD ($)
shares in Thousands, $ in Thousands
Total
Total Shareholders’ Equity
Shares of Beneficial Interest at Par Value
Additional Paid in Capital
Distributions in Excess of Net Income
Accumulated Other Comprehensive Income (Loss)
Non- controlling Interests in Subsidiary
Beginning balance (in shares) at Dec. 31, 2020     84,409        
Beginning balance at Dec. 31, 2020 $ 1,321,109 $ 1,320,787 $ 844 $ 1,649,366 $ (298,860) $ (30,563) $ 322
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net (loss) income 16,384 16,384     16,384    
Unrealized (loss) gain on interest rate derivatives 3,673 3,673       3,673  
Loss on interest rate derivatives 5,760 5,760       5,760  
Amortization of swap settlements 2,039 2,039       2,039  
Distributions to noncontrolling interests (15)           (15)
Dividends (80,018) (80,018)     (80,018)    
Equity offerings, net of issuance costs (in shares)     1,636        
Equity offerings, net of issuance costs $ 40,462 40,462 $ 17 40,445      
Shares issued under Dividend Reinvestment Program (in shares) 75   75        
Shares issued under Dividend Reinvestment Program $ 1,744 1,744   1,744      
Share grants, net of forfeitures and tax withholdings (in shares)     141        
Share grants, net of forfeitures and tax withholdings 5,924 5,924 $ 2 5,922      
Ending balance (in shares) at Dec. 31, 2021     86,261        
Ending balance at Dec. 31, 2021 1,317,062 1,316,755 $ 863 1,697,477 (362,494) (19,091) 307
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net (loss) income (30,868) (30,868)     (30,868)    
Unrealized (loss) gain on interest rate derivatives 2,819 2,819       2,819  
Amortization of swap settlements 2,039 2,039       2,039  
Distributions to noncontrolling interests (9)           (9)
Dividends (59,646) (59,646)     (59,646)    
Equity offerings, net of issuance costs (in shares)     1,032        
Equity offerings, net of issuance costs $ 26,849 26,849 $ 10 26,839      
Shares issued under Dividend Reinvestment Program (in shares) 47   47        
Shares issued under Dividend Reinvestment Program $ 1,030 1,030   1,030      
Share grants, net of forfeitures and tax withholdings (in shares)     194        
Share grants, net of forfeitures and tax withholdings $ 4,510 4,510 $ 2 4,508      
Ending balance (in shares) at Dec. 31, 2022 87,534   87,534        
Ending balance at Dec. 31, 2022 $ 1,263,786 1,263,488 $ 875 1,729,854 (453,008) (14,233) 298
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net (loss) income (52,977) (52,977)     (52,977)    
Unrealized (loss) gain on interest rate derivatives (764) (764)       (764)  
Amortization of swap settlements 2,039 2,039       2,039  
Distributions to noncontrolling interests (8)           (8)
Dividends $ (63,406) (63,406)     (63,406)    
Equity offerings, net of issuance costs (in shares)     0        
Shares issued under Dividend Reinvestment Program (in shares) 28   28        
Shares issued under Dividend Reinvestment Program $ 497 497   497      
Share grants, net of forfeitures and tax withholdings (in shares)     305        
Share grants, net of forfeitures and tax withholdings $ 5,183 5,183 $ 4 5,179      
Ending balance (in shares) at Dec. 31, 2023 87,867   87,867        
Ending balance at Dec. 31, 2023 $ 1,154,350 $ 1,154,060 $ 879 $ 1,735,530 $ (569,391) $ (12,958) $ 290